Category: Cardiovascular
Cardiovascular market research reports by Frost & Sullivan
-
Pipeline Assessment for Cardiovascular Diseases
Pipeline Assessment for Cardiovascular Diseases Advanced Drug Modalities Fuel Cardiovascular Therapeutics Future Growth Potential Globally, CVD is the leading cause of death, with resurgence in higher-income countries and higher prevalence in low- and middle-income countries. While there have been m ... Read More
-
CGT Research Outlook and Technology Growth Opportunities
CGT Research Outlook and Technology Growth Opportunities CGT Landscape Assessment The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and ... Read More
-
Global Precision Cardiometabolic Growth Opportunities
Global Precision Cardiometabolic Growth Opportunities Cardiometabolic diseases, including cardiovascular disease (which encompasses coronary artery diseases, chronic/congestive heart failure, stroke, and hypertension), type 2 diabetes, and obesity, have been increasing globally. As a result, the hea ... Read More
-
Global Stroke Care Continuum, Trends, Growth Opportunities and Forecast to 2027
Global Stroke Care Continuum, Trends, Growth Opportunities and Forecast to 2027 Advanced technological solutions boosts future growth potential and enhance stroke outcomes Stroke is one of the major causes of disability and death globally. High prevalence of stroke and growing stroke economic burden ... Read More
-
Global Nutritional Lipids Growth Opportunities
Global Nutritional Lipids Growth Opportunities Food & Nutrition Industry Demand for MCT and Consumer Preference for Sustainably Sourced Omega-3s Drive Potential In this research service, Frost & Sullivan provides qualitative and quantitative analyses of nutritional lipid ingredients such as omega-3 ... Read More
-
Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025
Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025 Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with c ... Read More
-
Global Neurovascular Disease Management Growth Opportunities
Global Neurovascular Disease Management Growth Opportunities The global prevalence of stroke is estimated to be about 100 million as of 2021. In the past 30 years, improvements in stroke prevention, acute treatment, and neuro-rehabilitation have contributed to a significant reduction in the burden o ... Read More
Research Assistance
